ArriVent BioPharma, Inc.
AVBP • NASDAQ • Stock Fundamentals
ArriVent BioPharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Zhengbin Yao, with a market cap of $1.4B.
Market Cap$1.4B
Employees40.0
CEOZhengbin Yao
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
ArriVent BioPharma, Inc. FAQ
Common questions about ArriVent BioPharma, Inc.
ArriVent BioPharma, Inc. (AVBP) has a market capitalization of $1.4B and trades on NASDAQ.
ArriVent BioPharma, Inc. has approximately 40 employees.